Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Mazzon

Showing results (371-380 of 492) with videos related to

Pageof 50
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 8, 2006
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord traumaSalvatore Cuzzocrea, Tiziana Genovese, Emanuela Mazzon, et al.
Shock (Augusta, Ga.)|October 19, 2006
Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosanRosanna Di Paola, Emanuela Esposito, Emanuela Mazzon, et al.
Respiratory Research|November 23, 2006
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injuryMarco Failla, Tiziana Genovese, Emanuela Mazzon, et al.
Brain Sciences|January 23, 2020
Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple SclerosisMaria Sofia Basile, Emanuela Mazzon, Katia Mangano, et al.
Experimental and Therapeutic Medicine|February 28, 2020
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disordersMaria Cristina Petralia, Emanuela Mazzon, Katia Mangano, et al.
Gastroenterology|November 11, 2008
Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitisLorenza Cannarile, Salvatore Cuzzocrea, Luca Santucci, et al.
Oncotarget|May 1, 2018
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approachKatia Mangano, Emanuela Mazzon, Maria Sofia Basile, et al.
Frontiers in Oncology|November 22, 2019
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic TargetsMaria Sofia Basile, Emanuela Mazzon, Paolo Fagone, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusionNimesh S A Patel, Prabal K Chatterjee, Rosanna Di Paola, et al.
Therapeutics and Clinical Risk Management|October 13, 2018
A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patientsAgnese Gugliandolo, Federica Longo, Maria Giovanna Marrosu, et al.
Pageof 50

Showing results (371-380 of 492) with videos related to

Sort By:
Pageof 50
The Journal of Pharmacology and Experimental Therapeutics|April 8, 2006
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord traumaSalvatore Cuzzocrea, Tiziana Genovese, Emanuela Mazzon, et al.
Shock (Augusta, Ga.)|October 19, 2006
Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosanRosanna Di Paola, Emanuela Esposito, Emanuela Mazzon, et al.
Respiratory Research|November 23, 2006
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injuryMarco Failla, Tiziana Genovese, Emanuela Mazzon, et al.
Brain Sciences|January 23, 2020
Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple SclerosisMaria Sofia Basile, Emanuela Mazzon, Katia Mangano, et al.
Experimental and Therapeutic Medicine|February 28, 2020
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disordersMaria Cristina Petralia, Emanuela Mazzon, Katia Mangano, et al.
Gastroenterology|November 11, 2008
Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitisLorenza Cannarile, Salvatore Cuzzocrea, Luca Santucci, et al.
Oncotarget|May 1, 2018
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approachKatia Mangano, Emanuela Mazzon, Maria Sofia Basile, et al.
Frontiers in Oncology|November 22, 2019
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic TargetsMaria Sofia Basile, Emanuela Mazzon, Paolo Fagone, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusionNimesh S A Patel, Prabal K Chatterjee, Rosanna Di Paola, et al.
Therapeutics and Clinical Risk Management|October 13, 2018
A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patientsAgnese Gugliandolo, Federica Longo, Maria Giovanna Marrosu, et al.
Pageof 50